YH, L., QM, L., NH, P., XD, Z., HL, H., JP, C., & GX, H. (2019). Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro. Basic & clinical pharmacology & toxicology, 125(4), 337. https://doi.org/10.1111/bcpt.13246
Chicago Style (17th ed.) CitationYH, Li, Lin QM, Pang NH, Zhang XD, Huang HL, Cai JP, and Hu GX. "Functional Characterization of 27 CYP3A4 Protein Variants to Metabolize Regorafenib in Vitro." Basic & Clinical Pharmacology & Toxicology 125, no. 4 (2019): 337. https://doi.org/10.1111/bcpt.13246.
MLA (9th ed.) CitationYH, Li, et al. "Functional Characterization of 27 CYP3A4 Protein Variants to Metabolize Regorafenib in Vitro." Basic & Clinical Pharmacology & Toxicology, vol. 125, no. 4, 2019, p. 337, https://doi.org/10.1111/bcpt.13246.